Trial Profile
Clinical Trials Insight: 700053423
Status:
Not stated
Phase of Trial:
Phase I
Latest Information Update: 09 Feb 2010
Price :
$35
*
At a glance
- Drugs AP 1030 (Primary)
- Indications Diabetes mellitus
- Focus Adverse reactions
- Sponsors Action Pharma
- 09 Feb 2010 New trial record.